Lucent, Inc. (LUCN)
OTCMKTS · Delayed Price · Currency is USD
5.25
-0.02 (-0.38%)
Aug 8, 2025, 4:00 PM EDT

Theseus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
8267----
Upgrade
Enterprise Value
8267----
Upgrade
Last Close Price
5.274.31----
Upgrade
PB Ratio
-11.42-3794.36----
Upgrade
Debt / Equity Ratio
--0.38-0.49-0.38--
Upgrade
Current Ratio
-5376.97--0.758.07
Upgrade
Return on Equity (ROE)
-----269.48%-64.75%
Upgrade
Return on Assets (ROA)
-----90.76%-33.92%
Upgrade
Return on Capital (ROIC)
-----168.43%-40.47%
Upgrade
Earnings Yield
-0.41%-0.02%----
Upgrade
Buyback Yield / Dilution
------3.99%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.